BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 12165862)

  • 1. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
    Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
    Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
    Bell SM; Zuo J; Myers RM; Knowles MA
    Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial deletion of 11q13 sequences in HeLa cells.
    Srivatsan ES; Bengtsson U; Manickam P; Benyamini P; Chandrasekharappa SC; Sun C; Stanbridge EJ; Redpath JL
    Genes Chromosomes Cancer; 2000 Oct; 29(2):157-65. PubMed ID: 10959095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
    Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
    Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A region on human chromosome 4 (q35.1-->qter) induces senescence in cell hybrids and is involved in cervical carcinogenesis.
    Backsch C; Rudolph B; Kühne-Heid R; Kalscheuer V; Bartsch O; Jansen L; Beer K; Meyer B; Schneider A; Dürst M
    Genes Chromosomes Cancer; 2005 Jul; 43(3):260-72. PubMed ID: 15838843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangement of chromosome band 11q13 in HeLa cells.
    Jesudasan RA; Slovak ML; Sen S; Srivatsan ES
    Anticancer Res; 1994; 14(5A):1727-33. PubMed ID: 7847806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines.
    MacGrogan D; Alvarez S; DeBlasio T; Jhanwar SC; Nimer SD
    Oncogene; 2001 Jul; 20(31):4150-60. PubMed ID: 11464281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mapping of chromosome 3p in human uterine cervical cancer.
    Kohno T; Takayama H; Hamaguchi M; Takano H; Yamaguchi N; Tsuda H; Hirohashi S; Vissing H; Shimizu M; Oshimura M
    Oncogene; 1993 Jul; 8(7):1825-32. PubMed ID: 8099726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
    Zhang Z; Gerhard DS; Nguyen L; Li J; Traugott A; Huettner PC; Rader JS
    Genes Chromosomes Cancer; 2005 May; 43(1):95-103. PubMed ID: 15672406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.